Nonmedical Use of Prescription ADHD Stimulant Medications Among Adults in a Substance Abuse Treatment Population: Early Findings From the NAVIPPRO Surveillance System

Objective: To examine nonmedical use (NMU) of prescription ADHD stimulants among adults evaluated for substance abuse treatment. Method: 147,816 assessments from the National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO) system (10/01/2009 through 03/31/2012) examined NMU prevalence, routes of administration (ROA), and diversion sources. Results: Past 30-day NMU for prescription stimulants (1.29%) was significantly lower than that of prescription opioids (19.79%) or sedatives (10.62%). For stimulant products, NMU for Adderall was 0.62, followed by Adderall XR (0.42), Ritalin (0.16), Vyvanse (0.12), and Concerta (0.08); product differences likely have limited clinical relevance given the low estimates (
Source: Journal of Attention Disorders - Category: Psychiatry Authors: Tags: Current Perspectives Source Type: research

Related Links:

While recreational marijuana is legal in 11 states as of November 2019, more states gravitating toward legalizing the recreational use of the substance, and 33 states allowing medical marijuana, there’s apparently no stopping this trend. Cannabis, in the form of marijuana, hemp, and cannabidiol (CBD)  is being used for pain relief, to alleviate stress, cope with anxiety, and a number of other mental health disorders and addictions. Yet, there’s a dearth of clinical studies that have been conducted on the overall effects on a user’s health. Clearly, as Crain’s Detroit Business points out, more ...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Medications Substance Abuse Cannabis Marijuana Source Type: blogs
On October 26th, DEA National Take Back Day will once again address a crucial public safety issue. According to the National Survey on Drug Use and Health, 9.9 million Americans misuse controlled prescription drugs – and that study indicates that most of these prescription drugs were either obtained from family and friends or found in the most-neglected staple of every bathroom: the medicine cabinet. What’s the Purpose of DEA National Take Back Day? DEA National Take Back Day gives individuals the chance to dispose of their unwanted prescription drugs in a safe, judgment-free environment. Cleaning out the aver...
Source: Cliffside Malibu - Category: Addiction Authors: Tags: Addiction Addiction to Pharmaceuticals Painkiller dea national take back day opioids prescription drug abuse prescription drug addiction prescription drug detox prescription drug use prescription drugs prescription medication prescri Source Type: blogs
This study tests whether ADHD is associated with a pervasive tendency to engage in risky behav...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
__________ Sleep Therapy for the Masses May Be Coming to You Soon (The New York Times): “CVS Health wants to help millions of American workers improve their sleep. So for the first time, the big pharmacy benefits manager is offering a purely digital therapy as a possible employee benefit. The company is encouraging employers to cover the costs for their workers to use Sleepio, an Sleepio app featuring a cartoon therapist that delivers behavior modification lessons. CVS Health’s push could help mainstream the nascent business of digital therapeutics, which markets apps to help treat conditions like schizophrenia...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Technology Big Health cognitive-behavioral-therapy CVS Health digital therapeutics digital therapy mental health Novartis sleep sleep aid medications Sleepio Source Type: blogs
Conclusion/Importance: Brief screenings for ADHD, other psychiatric disorders and sexual risk behaviors can provide data for tailoring substance abuse services to improve adolescent health outcomes for high-risk subgroups. PMID: 31502500 [PubMed - as supplied by publisher]
Source: Substance Use and Misuse - Category: Addiction Tags: Subst Use Misuse Source Type: research
TUESDAY, Aug. 27, 2019 -- Swedish researchers think they have honed in on why people with attention-deficit/hyperactivity disorder (ADHD) are more likely to die prematurely. Accidental injuries, suicide and substance abuse all play a part, and...
Source: - Daily MedNews - Category: General Medicine Source Type: news
– Somryst app by Pear Therapeutics Digital therapeutics have potential but commercial success unproven (Vantage): “Developing drugs to treat disorders of the central nervous system is famously fraught with difficulty. Several companies, including Pear Therapeutics and Dthera, are taking a wildly different approach: digital therapeutics. These are pieces of software designed to treat disease that are regulated, prescribed and even paid for as if they were drugs … Pear is so far the only company to have brought a digital therapeutic to market – but it is by no means the only company in this space. Ak...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Technology Akili Interactive AKL-T01 Click Therapeutics cognitive dysfunction digital therapeutics Dthera Pear Therapeutics Somryst Source Type: blogs
In addition to helping kids calm down and concentrate in school, the review also found that the drugs help children avoid a lot of long-term negative consequences associated with ADHD, including depression, substance abuse and even driving problems.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Conclusions: Bipolar disorder is common among primary care patients presenting with depression; it is often treated exclusively in primary care. Clinicians should be alert for symptoms of bipolar disorder in undiagnosed patients, know what symptoms probabilistically suggest bipolar versus unipolar depression, have expertise in providing ongoing treatment to diagnosed patients, and be knowledgeable about managing common medication-related side effects and comorbidities. Prompt and accurate diagnosis is critical. PMID: 31311335 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
There are well known behavioral complications of ADHD at adulthood such as learning difficulties resulting in lower education attainments; increased rate of car and other accidents; substance abuse; misconduct...
Source: Health Economics Review - Category: Health Management Authors: Tags: Research Source Type: research
More News: Adderall | Addiction | ADHD | Concerta | Psychiatry | Ritalin | Substance Abuse | Substance Abuse Disorders | Vyvanse